iShares US Pharmaceuticals ETF
IHE
IHE
155 hedge funds and large institutions have $359M invested in iShares US Pharmaceuticals ETF in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $374M → $359M (-$14.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
155
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$10.1M | |
| 3 | +$4.43M | |
| 4 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
+$3.83M |
| 5 |
Goldman Sachs
New York
|
+$1.93M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$8.25M | |
| 3 | -$2.87M | |
| 4 |
SCA
Southern Capital Advisors
Jackson,
Tennessee
|
-$2.84M |
| 5 |
KDA
Kraft Davis & Associates
St. Louis,
Missouri
|
-$1.74M |